The Pulse of Regulation.
The Regulatory Briefing
The week in regulation, in one read.
Every Tuesday morning: the decision that mattered, the rest of the week in short, and the dates coming next. Written for the people who file, inspect, approve and sign. Sourced to the primary record.
Free. One email a week. Unsubscribe with one click. How we handle your address.
What is in every issue.
The lead
The one decision, guidance or enforcement action that changes what teams do next, with a plain statement of why it matters.
The rest of the week
Approvals, clearances, complete response letters, draft and final guidance, inspections and recalls across FDA, EMA, MHRA, EU MDR and IVDR, and ICH. A line each, linked to the full story.
The dates ahead
Decision dates, advisory committees, hearings and comment deadlines coming up, so nothing on the calendar arrives as a surprise.
Free when you subscribe
FDA Key Dates: the next 90 days.
A PDF calendar of the decision dates, advisory committees, hearings and comment deadlines we have reported, each linked to its sourced story. It arrives the moment you confirm your address, and the link always opens the current edition.
How we report.
- Every story is sourced to the primary document: the approval letter, the Federal Register notice, the guidance itself.
- We say what changed, what it means, and what nobody knows yet. Reporting, never regulatory or legal advice.
- One email a week. No daily noise, and sponsored content is always labelled as such.
- Your address is used for the newsletter and nothing else. Leave with one click, any time.
Start with Tuesday’s issue.
You will get one email asking you to confirm. Nothing else arrives until you do.